An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Condition:   Primary Immunodeficiency Disease Intervention:   Biological: IGSC 20% infusion Sponsor:   Takeda Not yet recruiting

Source: ClinicalTrials.gov - April 13, 2021 Category: Research Source Type: clinical trials